203 filings
ARS
2023 FY
VYGR
Voyager Therapeutics Inc
25 Apr 24
Annual report to shareholders
5:22pm
DEFA14A
VYGR
Voyager Therapeutics Inc
25 Apr 24
Additional proxy soliciting materials
5:20pm
DEF 14A
VYGR
Voyager Therapeutics Inc
Definitive proxy
25 Apr 24
5:20pm
8-K
VYGR
Voyager Therapeutics Inc
2 Apr 24
Departure of Directors or Certain Officers
4:05pm
8-K
VYGR
Voyager Therapeutics Inc
13 Mar 24
Other Events
7:03am
S-8
hyne6o4f4i f1vfp
28 Feb 24
Registration of securities for employees
5:16pm
8-K
xqdxvfndky382
28 Feb 24
Voyager Therapeutics Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
4:00pm
D
2jxsfaj4n2 zlv8
17 Jan 24
$20.00 mm in equity, sold $20.00 mm, 1 investor
4:20pm
8-K
gm1klo5r4mkq0e0
8 Jan 24
Voyager Therapeutics Announces Pricing of Public Offering
4:49pm
424B5
apbf9 1rgkhwyz4n5z
8 Jan 24
Prospectus supplement for primary offering
4:04pm
424B5
3ufhew75l3dw
4 Jan 24
Prospectus supplement for primary offering
5:20pm
8-K
f2he21mzi 442ocp
2 Jan 24
Entry into a Material Definitive Agreement
7:05am
8-K
zund6mh
6 Dec 23
Voyager Therapeutics Announces Selection of Development Candidate for SOD1 Amyotrophic Lateral Sclerosis Gene Therapy Program
7:04am
8-K
1uon6 fcx3hu
6 Nov 23
Voyager Therapeutics Reports Third Quarter 2023 Financial and Operating Results
4:00pm
8-K
ex0xn35
16 Aug 23
Entry into a Material Definitive Agreement
4:18pm
8-K
hiip3 0ea
3 Aug 23
Voyager Therapeutics Reports Second Quarter 2023 Financial and Operating Results
7:00am
8-K
nlvomw14g14b0tt
10 Jul 23
Other Events
8:04am